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Abstract
The objective of this study was to compare the responsiveness and assess the concurrent validity of two functional health status instru-
ments, the Dartmouth COOP charts and the SF-36 in chronic low-back pain (CLBP) patients. The data came from 129 of 174 patients who
participated in a randomized clinical trial of the therapeutic management of CLBP. Reliable and valid disease-speci®c outcomes, patient-
rated low-back pain and disability, were used as external criteria (EC) to identify improved and non-improved patients. Unpaired t-statistics
and receiver operating characteristic (ROC) curve calculations were used to quantify responsiveness. The two instruments had suf®cient and
very similar responsiveness using both EC. Comparisons between improved and non-improved patients for the COOP charts and SF-36,
respectively, using pain as EC, yielded differences which translated into large effect sizes (0.8 and 0.7) (P  0:0008 and 0.003). Using
disability as EC, differences of moderate effect size were found (0.5 and 0.6) (P  0:02 and 0.002). The ROC curve calculations using pain as
EC resulted in areas under the curve of 0.76 (95% CI: 0.64, 0.88) for the COOP charts, and 0.74 (95% CI: 0.60, 0.88) for the SF-36. The
corresponding areas using disability as EC were 0.67 (95% CI: 0.55, 0.79) and 0.72 (95% CI: 0.60, 0.84). The best cut-off point in both
instruments for differentiating between improved and non-improved patients was approximately six percentage points. The constructs of
functional health status, as re¯ected in the global scores of the two instruments, are highly correlated (r  0:82). Six of the instruments' nine
dimensions are moderately to highly correlated (r  0:52 to 0.86), and the overall canonical correlation was high (R  0:9). In conclusion,
both instruments seem equally suitable for use as outcome measures in clinical trials on CLBP. The COOP charts are faster to ®ll out and
score. q 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.
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1. Introduction
Psychosocial factors play an important role in in¯uencing
the course of chronic low-back pain (CLBP) (Deyo and
Diehl, 1983). Instruments to measure functional health
status, including physical, emotional and social functioning,
have been around for many years, but in general have been
too lengthy for both clinical and research purposes (Deyo
and Diehl, 1983). Within the last 10 years briefer functional
health status questionnaires have been used with increasing
frequency as important outcomes in randomized clinical
trials (RCTs) (Anderson et al., 1993). Two popular instru-
ments are the SF-36 and the COOP charts. An early version
of the SF-36 (the MOS short form) has been utilized in the
large Medical Outcome study in over 20 000 patients and
was proven to be reliable, valid and capable of creating
distinct health pro®les for patients with different chronic
conditions, including CLBP (Stewart et al., 1989).
The cooperative (COOP) chart system was developed by
the Dartmouth COOP Project Network of community prac-
tices for use in primary care settings (Nelson et al., 1990a;
1983; Shigemoto, 1990). This instrument has been shown to
be reliable and valid when tested on several thousands of
patients in diverse primary care settings in United States,
Europe and Japan (Nelson et al., 1987, 1990; Meyboom-de
Jong et al., 1990; Kinnersley et al., 1994). The COOP charts
and the MOS short form have been compared and have
shown similar sensitivity in detecting the effects of several
prevalent diseases, such as heart disease and depression, on
functional health status (Landgraf, 1990).
Besides reproducibility and validity, another very impor-
tant property of an outcomes instrument is the ability to
capture clinically important change in speci®c disorders
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(Deyo et al., 1991; van Bennekom et al., 1996). This sensi-
tivity to change in a patient's condition, as de®ned by a
meaningful external criterion (EC), is termed responsive-
ness. Both the COOP charts and the SF-36 have been used
internationally as important outcomes in clinical trials for a
variety of clinical conditions, but their responsiveness has
not been evaluated in CLBP patients. The purpose of this
study was to compare responsiveness and assess concurrent
validity of both instruments in a sample of CLBP patients in
the context of a randomized clinical trial (RCT).
2. Methods
The main purpose of the RCT was to study the relative
ef®cacy of three different treatment regimens for CLBP in
174 patients aged 20±60 years. Patients were recruited
through newspaper advertisement. All patients were treated
in a primary contact multidisciplinary outpatient clinic.
There is evidence to suggest that suf®cient similarity exists
between patients recruited through advertising and primary
clinical settings to make generalization of ®ndings from
studies like ours possible (Deyo et al., 1990; Koes et al.,
1992).
The therapeutic interventions consisted of 11 weeks of
spinal manipulative therapy (SMT) combined with trunk
strengthening exercises or trunk stretching exercises, or
trunk strengthening exercises combined with a prescription
of non-steroidal anti-in¯ammatory medication. The results
of this RCT have been reported elsewhere (Bronfort et al.,
1996). One of the secondary research questions of the RCT
was to compare the responsiveness and to assess the concur-
rent validity of two functional health status instruments, the
COOP charts and the SF-36. For valid comparison the two
instruments were administered in random order at baseline
and after 11 weeks of therapy. Both instruments' raw scores
for each dimension were transformed into percentage scores
to allow for direct comparison. The percentage scores of all
nine dimensions of each instrument were summed and
divided by 9 to arrive at a global score. The respective
global scores were thus constructed without weighting of
the individual dimensions.
2.1. Responsiveness
Responsiveness is de®ned as the ability of an outcomes
instrument to detect clinically important changes in a speci-
®c condition. The methods used to quantify responsiveness
require the use of at least one valid EC of improvement.
2.2. External criteria of improvement
For the purposes of this study the external criteria (EC)
for determining improved and non-improved patients were
based on two low-back speci®c outcome measures in our
trial, patient-rated low-back pain (LBP) severity and the
Roland±Morris low-back disability index (RMI). Patient-
rated LBP severity was recorded on an 11 box scale for
ease of administration and scoring. Each box has a number
with anchors at 0 denoting no symptoms and at 10 denoting
the highest severity of pain. This pain scale has been shown
to have reliability and validity comparable to the 10 cm
visual analog scale (Jaeschke et al., 1990). The RMI consists
of 24 yes/no questions describing different types of restric-
tion in daily activities speci®cally due to LBP (e.g. `because
of my back, I lie down to rest more often'). This instrument
has measures of reliability, validity and responsiveness
similar to the much longer, highly reliable and valid sick-
ness impact pro®le (SIP) from which it was derived (Roland
and Morris, 1983). Both EC have been used extensively as
main outcomes in RCTs on LBP (Deyo, 1986; Deyo et al.,
1994) and recently been shown to be highly responsive
measures in chronic LBP patients (Beurskens et al., 1996).
The difference between improved and non-improved
patients had to amount to a minimal clinically important
difference (MCID). MCID was de®ned as the smallest
difference in score of a particular outcome that patients
would consider bene®cial and which would form the basis
for changing therapeutic management in the absence of
serious side effects and prohibitive costs (Jaeschke et al.,
1989). Data from most studies which have addressed this
issue suggest, regardless of the clinical condition, that an
MCID, which usually translates into an ES of approximately
0.5, corresponds to a change in patient rated pain of approxi-
mately 8±10 percentage points (Jaeschke et al., 1989; Gold-
smith et al., 1993; Juniper et al., 1994). The effect size
represents a unitless standardized difference. In this exam-
ple the effect size is derived at by dividing the difference in
means between two groups with the standard deviation of
the difference. An effect size of 1.0 is equivalent to a differ-
ence of 1 standard deviation in the sample. To assess the
relative magnitude of difference in scores, Cohen identi®ed
an effect size of 0.2 as small, 0.5 as moderate and 0.8 as
large (Cohen, 1988a). For both patient-rated LBP severity
and the RMI, we de®ned the improved group to have at least
10 percentage points improvement. Non-improved (stable,
unchanged) patients were de®ned as those having a range of
change scores from 25 to 15 percentage points. Conse-
quently, the rest of the patients, those with equivocal
improvement (5±10 percentage points) and those showing
deterioration (beyond 25 percentage points) were not
included in the responsiveness analysis. These criteria for
dividing patients into improved and non-improved indivi-
duals were used in connection with both of the methods for
quantifying responsiveness described below.
2.3. Methods for quantifying responsiveness
Two complementary methods for quantifying responsive-
ness were employed: unpaired t-statistics (Guyatt et al.,
1989) and receiver operating characteristic (ROC) curves
(Deyo et al., 1991; Hanley and McNeil, 1982).
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2.4. Unpaired t-tests
Deyo and Centor (1986) and Guyatt et al. (1989) de®ned
a responsive instrument as one that is clearly capable of
differentiating between improved and non-improved
patients as determined by one or more relevant EC. The
greater the difference in change scores between improved
and non-improved patients and the smaller the P-values, the
greater the responsiveness. Since P-values are dependent on
sample sizes, we divided the differences in change scores by
the pooled standard deviations of those change scores to
yield effect sizes for standardized comparisons among
instruments. Correction for effect size estimate bias asso-
ciated with small sample sizes (n , 50) was accomplished
using the method described by Hedges and Olkin (1985).
2.5. Receiver operating characteristic (ROC) curves
Deyo et al. (1991) have suggested that health status ques-
tionnaires can be regarded as diagnostic tests capable of
distinguishing between improved and unimproved patients.
Based on this concept it becomes possible to construct ROC
curves which describe the instrument's ability to detect
improvement or lack thereof on the basis of one or more
relevant and valid EC. The ROC curves display positive
(sensitivity) versus false positive (1-speci®city) rates for a
series of cut-off points in change scores. The area under the
ROC curve can be calculated and interpreted as the prob-
ability of correctly identifying improved patients from
randomly selected pairs of improved and unimproved
patients. An area of 0.5 is interpreted as no discriminatory
accuracy and 1.0 as complete accuracy. In addition, ROC
curves can be compared statistically, (Hanley and McNeil,
1983) as well as form the basis for deciding which cut-off
points are best capable of discriminating between improved
and non-improved patients (Hanley and McNeil, 1982).
2.6. Concurrent validity
Concurrent validity was assessed by calculating Pear-
son's product-moment correlation between global scores
of the COOP charts and the SF-36 at baseline and after 11
weeks of treatment (n  129). Canonical correlation was
used as an additional procedure for assessing concurrent
validity by correlating the individual sets of similar dimen-
sions of the two instruments. This procedure involves corre-
lation of two derived variables, each representing a
weighted combination of the two sets of nine dimensions.
The canonical weights, similar to the beta weights of multi-
ple correlation, are calculated in a way that the correlation
of the two derived variables are maximized (Kachigan,
1986).
2.7. Statistical analysis
The software program True EpistatTM version 5,
(Richardson, Texas) was used to calculate the ROC curves,
to test for instrument differences in areas under the curve,
and to compare instrument sensitivity and speci®city. The t-
tests, Mann±Whitney tests, correlation coef®cients, and
canonical correlations were calculated using the statistical
software package Statistica for Windows ver. 5.0 by Stat-
soft, Inc.
3. Results
3.1. Characteristics of the subjects
Seventy-six percent (132 patients) of the initial 174
patients completed the intervention part of the study (11
weeks) and were available for all main outcome assess-
ments. COOP and SF-36 data were available at baseline
and week 11 for 129 of the 132 subjects. We investigated
the means, standard deviations, and minima and maxima for
all patients, including drop-outs, for baseline clinical and
demographic variables and all primary outcomes at the
three times of assessment. We were unable to identify any
patterns that suggested anything except that the data were
missing completely at random (MCAR) (Little and Rubin,
1987). MCAR is the term used to indicate that the missing-
ness is like a random sample, hence analyzing the comple-
ters has reduced power but should not be biased. This means
the drop-outs represent a random sample of patients in this
trial, and it is unlikely that data from these patients would
have changed the main results of the study.
The main demographic and clinical characteristics of the
subjects are summarized in Table 1. Sixty-seven percent had
jobs outside the home; 23% were self-employed; and 3%
were unemployed. Twenty-seven percent had manual labor
occupations.
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Table 1
Demographic and baseline clinical characteristicsa
Characteristic
No. of subjects 129
Age (year) 42.2 (9.2)
Gender (% female) 50.8
Working at full capacity at study entry (%) 91.9
Duration of current episode of low back pain (year)
(median)
2.0
Pain radiation to leg (%) 52.0
Previous hospitalization for low back pain (%) 6.4
Smoker (%) 15.9
Three or more previous episodes of low back pain (%) 48.4
Low back pain score (0±10 scale) 5.4 (1.5)
Low back disability score (Roland±Morris, 0±100 scale) 34.6 (18.3)
Global general health score (COOP charts, 0±100 scale) 64.2 (12.8)
Global general health score (SF-36, 0±100 scale) 65.2 (14.1)
a Values are means and standard deviations (SD) unless otherwise noted.
3.2. The main therapeutic outcomes
The results of our RCT has been reported elsewhere
(Bronfort et al., 1996). Clinically important and statistically
signi®cant improvement over time was evident in all the
major outcome measures in the entire study population,
but there were no important outcome differences between
interventions. The largest improvements were seen in
patient rated pain and disability, based on the mean changes
from baseline to after 11 weeks of treatment, which were
22.9 (95% CI: 26.7, 19.1) and 16.4 (95% CI: 19.3, 13.4)
percentage points, respectively. The improvement in global
score for the SF-36 was 11.0 percentage points (95% CI:
8.8, 13.3), and for the COOP charts, 11.2 percentage points
(95% CI: 9.0, 13.4). Figs. 1 and 2 display the change in
COOP and SF-36 individual dimension score pro®les and
global scores over time. The responsiveness in terms of
statistical power was greatest for patient-rated pain with
the pre-post treatment difference translating into an effect
size of 1.5 compared to 0.8 to 1.0 for the other three vari-
ables.
3.3. Responsiveness
Quanti®cation of responsiveness of the two general health
status instruments showed pronounced similarity with both
methods of analysis using both EC. The global change score
difference between improved and non-improved patients,
using patient-rated pain and low-back disability as EC
were all clinically important and statistically signi®cant
(Table 2). In regard to EC scores, of the 132 patients with
available data, those with improvement between 5 and 10
percentage points, for LBP severity (n  2 (2%)) and RMI
(n  15 (11%)), and those showing deterioration beyond -5
percentage points, for LBP severity (n  11 (8%)) and RMI
(n  10 (8%)), were not included in the analysis. The ROC
curve calculations are displayed in Figs. 3 and 4. Using pain
as EC resulted in an area under the curve of 0.76 (95% CI:
0.64, 0.88) for the COOP charts and 0.74 (95% CI: 0.60,
0.88) for the SF-36, (difference, P  0:76). The correspond-
ing areas using low-back disability as EC were 0.67 (95%
CI: 0.55, 0.79) and 0.72 (95% CI: 0.60, 0.84) (difference,
P  0:55). The best cut-off point for both the COOP charts
and the SF-36 in differentiating between improved and non-
improved patients was estimated at 6 percentage points (the
data point closest to the upper left corner of the ROC graph).
The sensitivity/speci®city using this cut-off point were 74%/
80% and 74%/65% for the COOP charts and the SF-36,
respectively. The four areas under the curve calculations
showed that both instruments possess a moderate and very
similar degree of responsiveness in CLBP patients.
3.4. Concurrent validity
Only the COOP charts were administered twice during
the 1 week baseline period (n  173), and test-retest relia-
bility was high (0.82) as assessed by the intraclass correla-
tion coef®cient. The coef®cients for the individual nine
dimensions varied between 0.51 and 0.79. The internal
consistency coef®cients (Chronbach's Alpha) were 0.77
and 0.8 for the COOP Charts and the SF-36, respectively.
These test-retest and internal consistency coef®cients are
similar in magnitude to those found in other studies of
both the COOP charts and the SF-36 (Beaton et al., 1997;
Kinnersley et al., 1994; Nelson et al., 1990b). A high level
of concurrent validity was present when correlating SF-36
and COOP Chart global scores at baseline (r  0:82, 95%
CI: 0.77, 0.86), and after 11 weeks of therapy (r  0:85,
95% CI: 0.79, 0.89). When correlating the individual sets
of dimensions from both instruments, the overall canonical
correlation coef®cients were 0.90 at baseline, and 0.91 at
week 11, both statistically signi®cant (P , 0:0001). The
individual dimensions in the two instruments do not
measure identical constructs, but six of them that describe
very similar phenomena do show moderate to high correla-
tions (0.52±0.86), all statistically signi®cant at or below the
0.001 level (see Table 3).
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Fig. 1. SF-36 dimension score pro®le in percentage points at baseline and at
week 11. (Higher scores are better regardless of dimension). PF, Physical
functioning, RP, Role physical; RE, Role emotional; BP, Bodily pain; GH,
General health; VI, Vitality; SF, Social functioning; MH, Mental health;
HT, Health transition; GS, Global score.
Fig. 2. COOP Chart dimension score pro®le in percentage points at base-
line and at week 11. (Higher scores are better regardless of dimension). PF,
Physical ®tness; EM, Emotional; DA, Daily activity; SA, Social activity;
BP, Bodily pain; CH, Change in health; OH, Overall health; SS, Social
support; QL, Quality of Life; GS, Global score.
4. Discussion
There exists some uncertainty regarding optimal methods
for assessing responsiveness of outcome instruments and for
comparing competing instruments. Also, different methods
of analysis yield different magnitudes of responsiveness
(Wright and Young, 1997). A common method of assessing
responsiveness is to compare scores of one or more new
instruments before and after an ef®cacious treatment
(Liang et al., 1990; Deyo et al., 1991). However, no clearly
ef®cacious or `gold standard' treatment currently exists for
CLBP. Another method of quantifying responsiveness is to
compare effect sizes de®ned as the change in mean pre/post
treatment scores divided by the standard deviation of the
change score (Cohen, 1988b; Liang et al., 1990). Some
investigators advocate calculating the effect size using the
standard deviation of the change score in stable patients to
control for the non-speci®c changes in non-improved
patients (Guyatt et al., 1987; Tuley et al., 1991). The stan-
dard deviation of the pre-treatment score has also been used
for this purpose (Kazis et al., 1989).
We chose unpaired t-statistics (Guyatt et al., 1989) and
the receiver operating characteristic (ROC) curves (Hanley
and McNeil, 1982; Deyo et al., 1991) for assessment of
instrument responsiveness. These methods allowed the
determination of clinically important and statistically signif-
icant differences between improved and non-improved
patients. Additionally, the ROC method enabled us to test
whether the difference between the two instruments'
responsiveness was of statistical signi®cance (Hanley and
McNeil, 1983).
There is currently no consensus on what constitutes a
`gold standard' in choice of EC to represent improvement
when evaluating responsiveness of functional status instru-
ments, and further research is needed in this area (Deyo and
Centor, 1986; de Bruin et al., 1997). Examples of EC for
establishing patient improvement in other responsiveness
studies of speci®c clinical conditions are satisfaction with
care (Stucki et al., 1995), change in health, (Beaton et al.,
1997) pain improvement, clinician-rated improvement,
return to normal activities (Deyo and Centor, 1986), and
global perceived effect (Beurskens et al., 1996). Since
there is no `gold standard', a single generic outcome
measure is unlikely to serve as an optimal EC (Deyo and
Centor, 1986). Thus, we decided to use two complementary,
reliable, valid and responsive low-back speci®c instruments
as EC of improvement. The results were relatively consis-
tent using both EC, and increased our con®dence in the
correctness of the calculated responsiveness.
Although the use of global or unweighted aggregate
scores have been recommended for some health status
instruments, it has not been advocated by the instrument
developers of the two functional health status instruments
in this study. We ®nd, as have others (Beaton et al., 1997),
that for the purpose of clinical trials, where separate analysis
of multiple outcomes may seriously reduce statistical
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Table 2
Comparative responsiveness of the COOP charts and the SF-36 based on low back pain and disability as external criteria (EC)a
Outcome measure External criterion: patient-rated low-back pain
Improved patients
( $ 10% points on EC)
Non-improved patients










P-value Effect size of difference in
mean change (95% CI)
Low-back pain (EC) 32.63 (n  99) 14.9
COOP charts 13.48 (n  94) 11.8 3.83 (n  20) 8.6 9.65 3.46 0.0008 0.82 (0.32, 1.31)
SF-36 13.24 (n  98) 12.5 3.77 (n  20) 14.2 9.47 3.01 0.003 0.71 (0.22, 1.20)
External criterion: patient-rated low-back disability
Improved patients
( $ 10% points on EC)
Non-improved patients










P-value Effect size of difference in
mean change (95% CI)
Low-back disability
(EC)
24.92 (n  87) 12.6
COOP charts 13.80 (n  84) 12.7 7.73 (n  19) 6.5 6.07 2.32 0.02b 0.51 (0.01, 1.01)
SF-36 14.40 (n  87) 12.8 6.76 (n  20) 8.2 7.64 3.10 0.002b 0.61 (0.11, 1.10)
a The low-back pain, low-back disability and the health status instrument percentage point (%points) changes represent mean improvement in global scores
after 11 weeks of therapy compared to baseline.
b Since group variances were signi®cantly different, the non-parametric Mann±Whitney test was performed.
power, the global score (a pooled index) can be advanta-
geous. The global score may also be clinically meaningful if
it can be established, as in this study, that responsiveness to
change in the studied clinical condition is adequate.
However, the magnitude of change representing clinical
importance remains an open question. John Ware, the origi-
nal developer of the SF-36, has suggested that a change in
individual domain scores of 6±8 percentage points is clini-
cally important (pers. commun.). Certainly, the 9±11
percentage points improvement in global scores in the
LBP patients in this study translates into an important clin-
ical change and corroborates well with the 20±25 percentage
points improvement in the condition-speci®c patient-rated
low-back pain and disability. It should be noted that a
change of approximately 6 percentage points in global
score, the best cut-off point for both instruments in this
study, was capable of distinguishing between improved
and non-improved CLBP patients.
Similar global score changes may represent very different
individual dimension pro®le changes for different clinical
conditions. The SF-36 was used as one of the primary
outcome measures in a RCT on spinal manipulation versus
Amitriptyline for chronic muscle tension headache (Boline
et al., 1995). Corresponding with the difference in headache
pain ratings, the group difference of 5 percentage points in
the SF-36 global scores was primarily attributed to three of
the nine dimensions: health transition, general health
perception and emotional problems in relation to role-func-
tion. In contrast, in the present study on LBP patients, the
SF-36's bodily pain and physical problems in relation to
role-function, and the similar COOP Chart dimensions,
bodily pain and daily activity were the dimensions to
show the largest change. This appears to make intuitive
sense in terms of the clinical characteristics of these two
different disorders.
The results of our study showed suf®cient and very simi-
lar responsiveness of both instruments. Consistent with our
results, Jenkinson et al. (1995), using effect size statistics,
also found very similar responsiveness of the COOP charts
and SF-36 in 129 patients participating in a RCT on two
different surgical procedures for inguinal hernias. It must be
noted that our study sample was treated in a primary care
setting and consisted of chronic moderately severe back
pain patients of whom a relatively small percentage were
not working at full capacity. Therefore, additional evalua-
tion of these instruments is needed before it is known
whether the results of this study apply to more severely
af̄ icted back pain patients, who would often be receiving
care in tertiary chronic back pain centers.
Our study, as have others (Landgraf, 1990; Nelson et al.,
1990b; McHorney et al., 1992; Anderson et al., 1993),
showed that the individual dimensions or domains of the
SF-36 and the COOP charts are not identical, but do create
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Fig. 4. Receiver operating characteristic (ROC) curves for COOP and SF-
36 global change scores (baseline to week 11) based on patient-rated
disability as external criterion (EC), with $ 10 percentage points repre-
senting improved and 2 5±5 percentage points non-improved patients.
Fig. 3. Receiver operating characteristic (ROC) curves for COOP and SF-
36 global change scores (baseline to week 11) based on patient-rated low-
back pain as external criterion (EC), with $ 10 percentage points repre-
senting improved and 2 5±5 percentage points non-improved patients.
somewhat different patient pro®les. However, six of the
total of nine domains describing very similar constructs
are moderately to highly correlated. The construct of func-
tional health status as re¯ected in the global scores and the
canonical correlation analysis are also highly correlated.
Although not systematically assessed, our estimates of
mean time used by patients to complete the instruments
correspond with that reported in the literature, 2±5 min for
the COOP charts (Nelson et al., 1987) and 8±15 min for the
SF-36 (Weinberger et al., 1991; Beaton et al., 1997). The
COOP charts are faster and easier to score (Jenkinson et al.,
1995), but illustrations accompanying the text in the COOP
charts prevent them from being used as intended when
administered over the phone. However, at least two studies
involving different types of patients have shown that admin-
istering the COOP charts without the pictograms do not
seem to affect outcomes (Larson et al., 1992; Kempen et
al., 1997). This is not an issue with the SF-36.
Among the short functional health status instruments, the
SF-36 and the COOP charts seem to have the most wide-
spread use internationally (Landgraf and Nelson, 1992;
Wasson et al., 1992; Anderson et al., 1993; Bruusgaard et
al., 1993; Lam et al., 1994), and cross-cultural validation
studies are currently underway for both instruments (Ander-
son et al., 1993). The SF-36 is being assessed in 15 countries
for the purpose of validation and establishing norms to be
used in future international clinical trials (Anderson et al.,
1993). In 1988, the World Organization of General Practi-
tioners/Family Physicians (WONCA) chose the COOP
charts as the basis for developing an international system
for assessing functional health status (Landgraf and Nelson,
1992). As a result of these studies, revised and shorter
versions of both instruments are being developed and tested
(Ware et al., 1996). Although a substantial amount of
normative and condition-speci®c pro®les now exists espe-
cially for the SF-36 (Garratt et al., 1993; Jenkinson et al.,
1993), both instruments' responsiveness in various speci®c
patient populations requires further research.
5. Conclusions
Using two complementary methods of analysis, the
COOP charts and the SF-36 show moderate and very similar
responsiveness in CLBP patients. The construct of func-
tional health status, as re¯ected in the global scores of the
two instruments, are highly correlated. Six of the total nine
domains of each of the two instruments are moderately to
highly correlated. Both instruments seem equally suitable
for use as primary outcome measures in clinical trials on
CLBP. The COOP charts are faster to ®ll out and score.
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